Enzo Biochem (FRA:EZB) Gross-Profit-to-Asset % : 16.19% (As of Jan. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Enzo Biochem's annualized Gross Profit for the quarter that ended in Jan. 2024 was €15.51 Mil. Enzo Biochem's average Total Assets over the quarter that ended in Jan. 2024 was €95.81 Mil. Therefore, Enzo Biochem's annualized Gross-Profit-to-Asset % for the quarter that ended in Jan. 2024 was 16.19%.

Enzo Biochem Gross-Profit-to-Asset % Historical Data

The historical data trend for Enzo Biochem's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Gross-Profit-to-Asset % Chart

Enzo Biochem Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

22.77

21.43

46.71

15.49

11.33

Enzo Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															13.67	8.75	20.82	12.41	16.19

Competitive Comparison of Enzo Biochem's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Enzo Biochem's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzo Biochem's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Gross-Profit-to-Asset % falls into.

Enzo Biochem Gross-Profit-to-Asset % Calculation

Enzo Biochem's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jul. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jul. 2023 )	/	( (Total Assets (A: Jul. 2022 )	+	Total Assets (A: Jul. 2023 ))	/ count )
	=	10.456	/	( (74.326	+	110.18)	/ 2 )
	=	10.456	/	92.253
	=	11.33 %

Enzo Biochem's annualized Gross-Profit-to-Asset % for the quarter that ended in Jan. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jan. 2024 )	/	( (Total Assets (Q: Oct. 2023 )	+	Total Assets (Q: Jan. 2024 ))	/ count )
	=	15.512	/	( (100.674	+	90.953)	/ 2 )
	=	15.512	/	95.8135
	=	16.19 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jan. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Enzo Biochem Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzo Biochem (FRA:EZB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (FRA:EZB) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

NOTV VNRX BIOQ STIM PSNL PRE OCX MDXH TTOO XGN TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

ENZ:USA

Address

527 Madison Avenue, New York, NY, USA, 10022

Website

https://www.enzo.com

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

Enzo Biochem (FRA:EZB) Headlines

No Headlines